Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-07-17

Clinical Trial Update: Concurrent Training in Type 2 Diabetes [NA]

View source ↗

Summary

A sponsor update indicates that the University of Birmingham trial evaluating concurrent training for Type 2 Diabetes Mellitus has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Birmingham | Conditions: Type 2 Diabetes Mellitus | NA | Status: TERMINATED